Mohamed Elalfy
Contact Info
Office Hours
- Today
- -
Mohamed Elalfy
About Mohamed Elalfy
Mr. Mohamed Elalfy is a double-qualified consultant ophthalmologist in East Grinstead and Tunbridge Wells, who specialises in cataracts, laser eye surgery, refractive surgery, ocular surface and dry eye. He has more than 15 years’ experience in ophthalmology during which he has performed thousands of sight-saving surgeries.
Mr. Elalfy is a fellow of the Royal College of Ophthalmologists in London, the Royal College of Surgeons in Edinburgh, the Royal College of Physicians and Surgeons in Glasgow, the European Board of Ophthalmology and the International Council of Ophthalmology. He is an active member of the European Society of Cataract and Refractive Surgery, and of The European Cornea Society and Refractive Surgery.
Mr. Elalfy travels abroad as an invited guest to share his expertise through teaching and live surgeries. He is Fellowship Programme Director in Corneoplastic Unit, Queen Victoria Hospital where he trains four fellows annually.
He is also an ophthalmology examiner in two Royal Colleges and in The University of Brighton Independent Research Projects Programme in The Undergraduate Medical School, where he supervises the projects of medical students. Mr. Elalfy supervises Masters and Doctoral degree students in ophthalmology.
He holds multiple vocational diplomas from multiple awarding bodies. Having obtained two academic qualifications through his career of more than 15 years in ophthalmology and with more than 30 peer-reviewed publications, Mr. Elalfy puts evidence-based ophthalmology at the heart of his practice.
Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.